For US Healthcare Professionals

Qutenza Logo
Hero

Not an actual patient.

Clinical Data for QUTENZA

Results from a clinical study showing how QUTENZA provided sustained pain relief associated with painful diabetic peripheral neuropathy (DPN) of the feet.1,2

Efficacy

Actor portrayals.

Safety

Actor portrayals.

Patient Preference

Actor portrayals.

Continued Treatment

  • Carton with one topical system + Cleansing Gel: NDC #72512-928-01
  • Carton with two topical systems + Cleansing Gel: NDC #72512-929-01
  • Carton with four topical systems + Cleansing Gel: NDC #72512-930-01

References:

1.QUTENZA® [prescribing information]. Morristown, NJ: Averitas Pharma, Inc.2.Simpson DM, Robinson-Papp J, Van J, et al. Capsaicin 8% patch in painful diabetic peripheral neuropathy: a randomized, double-blind, placebo-controlled study. J Pain. 2017;18(1):42-53.